Global Insights: Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Expected to Surpass $3.48 Billion by 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Latest Market Insights for the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Industry?
The market size of raw materials for messenger ribonucleic acid (mrna) synthesis has seen a slight increase in recent times. The market is forecasted to expand from a value of $2.99 billion in 2024 to $3.03 billion in 2025, with a compound annual growth rate (CAGR) of 1.5%. This growth in the historical period can be ascribed to the progress in biomedical research, escalating interest in vaccines and therapeutics, the need for personalized medicine, readiness and response for outbreaks, and fundamental growth in the biotech industry.
The market size for raw materials used in the synthesis of messenger ribonucleic acid (mrna) is projected to experience consistent growth in the coming years. By 2029, it is anticipated to reach $3.48 billion, expanding at a compound annual growth rate (CAGR) of 3.5%. The projected growth in the forecast period is due to factors such as optimization of the supply chain, market expansion and commercialization, capital investment in biotechnology and pharmaceuticals, regulatory support and clearances, and expansion in therapeutics. Noteworthy trends expected in this forecast period include an increase in new market participants, quality maintenance and standardization, dealing with intellectual property rights and licenses, ensuring global accessibility and fairness, and a transition to sustainable and scalable production practices.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12336&type=smp
What Forces Are Driving The Growth Of The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Industry?
The mRNA synthesis raw materials market is set to expand due to the rising prevalence of cancer and chronic illnesses. Cancer is characterized as a condition where rogue cells grow without control, potentially spreading to other parts of the body from adjacent tissues through blood and lymph systems. Chronic diseases are broadly defined as conditions which last for a year or more, require ongoing medical attention, pose obstacles in daily activities, or both. mRNA synthesis raw materials play a crucial role in drug discovery, vaccine formation, and production of RNA-based therapeutics. These materials provide superior immunogenicity, enhanced efficacy, and shortened production time, thereby aiding in the treatment of cancer and chronic diseases. As per data from American Cancer Society Facts and Figures, a professional organization in the US, the country recorded around 1.9 million new cancer cases and about 609,360 fatalities in 2022. Their forecasts for 2023 show a slight surge with over 1.9 million fresh cancer cases and approximately 609,820 deaths. Consequently, the increasing occurrences of cancer and chronic ailments fuel the growth of mRNA synthesis raw materials market.
What Is The Overview Of Market Segmentation In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Industry?
The messenger ribonucleic acid (mrna) synthesis raw materials market covered in this report is segmented –
1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types
2) By Applications: Therapeutics Production, Vaccine Production, Other Applications
3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users
Subsegments:
1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents
2) By Nucleotides: Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides
3) By Plasmid DNA: Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA
4) By Other Types: Buffer Solutions, Enzymes, Other Auxiliary Materials
What Future Market Trends Are Projected For The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Industry?
Product innovations are becoming increasingly significant in the mRNA synthesis raw materials market, a trend that key industry players are capitalising on. These companies are focusing on the development of innovative products to secure their market position. As an example, Thermo Fisher Scientific, an American company specializing in instrumentation, reagents, consumables, and software services, launched Dynabeads Solutions in September 2022. These beads have the potential to expedite GMP-grade synthesis and purification of mRNA for vaccine production. Specifically designed for effortless solid-phase IVT of cell-free mRNA, Dynabeads Streptavidin for In Vitro Transcription enables the DNA template to be reused up to six times, simplifying plasmid creation and enhancing mRNA yield on scales from grams to kilos. Furthermore, it aids in creating an efficient workflow, enabling mRNA corporations to accelerate the transition from development to commercial launch.
Who Are The Primary Players Operating Across The Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
Major companies operating in the messenger ribonucleic acid (mRNA) synthesis raw materials market include Pfizer Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Moderna Inc., Agilent Technologies Inc., Lonza Group Ltd., Eurofins Scientific, Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Integrated DNA Technologies Inc., Sino Biological Inc., CureVac N.V., LGC Biosearch Technologies, Enzo Biochem Inc, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc, Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.
Get The Full Report Here:
Which Region Offers The Most Growth Potential For The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Through 2029?
North America was the largest region in the mRNA synthesis raw materials market in 2024. The regions covered in the messenger ribonucleic acid (mRNA) synthesis raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12336&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
